TY  - GEN
AU  - Detalle, Laurent
AU  - Stohr, Thomas
AU  - Palomo-Sanz, Concepcion
AU  - Piedra, Pedro A
AU  - Gilbert, Brian E
AU  - Mas-Lloret, Vicente
AU  - Millar, Andrena
AU  - Power, Ultan F
AU  - Stortelers, Catelijne
AU  - Allosery, Koen
AU  - Melero, Jose Antonio
AU  - Depla, Erik
PY  - 2016
DO  - 10.1128/AAC.01802-15
SN  - 0066-4804
UR  - http://hdl.handle.net/20.500.12105/9964
AB  - Respiratory syncytial virus (RSV) is an important causative agent of lower respiratory tract infections in infants and elderly individuals. Its fusion (F) protein is critical for virus infection. It is targeted by several investigational antivirals...
LA  - eng
PB  - American Society for Microbiology (ASM)
KW  - Administration, Inhalation
KW  - Animals
KW  - Antibodies, Neutralizing
KW  - Antibodies, Viral
KW  - Antiviral Agents
KW  - Female
KW  - Gene Expression
KW  - Humans
KW  - Lung
KW  - Male
KW  - Models, Molecular
KW  - Nasal Cavity
KW  - Neutralization Tests
KW  - Palivizumab
KW  - Pichia
KW  - Rats
KW  - Recombinant Proteins
KW  - Respiratory Syncytial Virus Infections
KW  - Respiratory Syncytial Viruses
KW  - Sigmodontinae
KW  - Single-Domain Antibodies
KW  - Viral Fusion Proteins
KW  - Viral Load
KW  - Virus
TI  - Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
TY  - research article
ER  -